Cetera Advisor Networks’s Celldex Therapeutics CLDX Stock Holding History

Cetera Advisor Networks’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-28	Closed	–	–	1520
2020 Q2	$0	Buy	+28	New	+$124	﹤0.01%	3437
2017 Q3	–	Sell	-726	Closed	-$27K	–	919
2017 Q2	$27K	Hold	726	–	–	﹤0.01%	914
2017 Q1	$38K	Hold	726	–	–	﹤0.01%	911
2016 Q4	$37K	Hold	726	–	–	﹤0.01%	858
2016 Q3	$44K	Buy	726 +47	+7%	+$2.93K	﹤0.01%	1023
2016 Q2	$44K	Buy	+679	New	+$43.1K	﹤0.01%	826
2013 Q4	–	Sell	-576	Closed	-$305K	–	766
2013 Q3	$305K	Buy	+576	New	+$198K	0.03%	483

Other funds holding CLDX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return